Pharma major Lupin Tuesday entered into a long-term strategic partnership with Germany-based biopharmaceutical firm Merck Serono for expansion of its portfolio initiative in emerging markets.
"This strategic partnership builds on the existing close collaboration between our two companies," said Vinod Dhawan, group president, Asia Pacific, Africa, Middle East and Latin America (AAMLA) for Lupin.
According to the pharma major, the agreement builds on an established working relationship between the two companies which could add up to 20 new products to the current portfolio. The first launches are expected in 2016.
Sales from the emerging market regions are one of the key growth drivers for Merck Serono amounting to close to 1.8 billion euro in 2013.
Lupin said it will develop products, provide dossiers and supply finished products to Merck Serono. Merck Serono will be the marketing authorization holder for the products, and will leverage its strong commercial and medical teams in emerging markets to bring new medicines in its portfolio to customers.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app